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ABSTRACT
The transcriptional regulator PlcR and its cognate
cell–cell signalling peptide PapR form a quorum-
sensing system that controls the expression of
extra-cellular virulence factors in various species
of the Bacillus cereus group. PlcR and PapR alleles
are clustered into four groups defining four pher-
otypes. However, the molecular basis for group
specificity remains elusive, largely because the
biologically relevant PapR form is not known. Here,
we show that the in vivo active form of PapR is
the C-terminal heptapeptide of the precursor, and
not the pentapeptide, as previously suggested.
Combining genetic complementation, anisotropy
assays and structural analysis we provide a detailed
functional and structural explanation for the group
specificity of the PlcR–PapR quorum-sensing
system. We further show that the C-terminal helix
of the PlcR regulatory domain, specifically the 278
residue, in conjunction with the N-terminal residues
of the PapR heptapeptide determines this system
specificity. Variability in the specificity-encoding
regions of plcR and papR genes suggests that
selection and evolution of quorum-sensing systems
play a major role in adaptation and ecology of
Bacilli.
INTRODUCTION
Important bacterial processes, such as the production
of antibiotics, induction of competence, sporulation
and expression of virulence factors, are controlled in
a multi-cellular manner via quorum-sensing systems.
These communication systems are based on the secretion
and recognition of cell–cell signalling molecules. Gram-
negative bacteria generally use acyl-homoserine lactones
as autoinducers, whereas in Gram-positive bacteria
quorum sensing is commonly mediated by peptides or
modiﬁed peptides. These peptides can act at diﬀerent
levels. In several Gram-positive bacteria, the sensor
protein of a two-component system recognizes the
inducer, triggering a phosphorylation cascade that targets
a cognate regulatory protein. This is the case in the
competence system, Com, of Streptococcus pneumoniae
and in the virulence system, Agr, of Staphylococcus aureus
(1,2). In others, for example the PrgX conjugative system
of Enterococcus faecalis, Rap phosphatases of Bacillus
subtilis and the PlcR regulator of Bacillus cereus, the
autoinducer directly binds the regulatory protein (3,4,16).
To gain further insight into the molecular mechanisms of
coordinated virulence development by direct peptide
recognition we carried out structure/function studies on
PlcR and its cell–cell signalling peptide PapR.
The B. cereus group comprises a number of highly
related species, which include B. thuringiensis, an insect
pathogen, and B. anthracis, the aetiological agent of
anthrax. The widespread presence of B. thuringiensis and
B. cereus in soil and food, and their close relationship with
B. anthracis make this group an important threat to public
health, and a potential source of new pathogens. Indeed,
B. cereus is generally regarded as a pathogen causing
food-borne gastroenteritis (5,6). However, some rare but
serious opportunistic non-gastrointestinal infections, for
example endophthalmitis and pneumonia, have also been
attributed to B. cereus (7–9). Bacillus cereus strains were
also recently found to be responsible for severe infections
resembling anthrax (10,11).
Several factors are involved in gastrointestinal and
non-gastrointestinal diseases associated with B. cereus,
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haemolysins, cytotoxins and various degradative enzymes
(5,6). Production of most of these exported virulence
factors is activated by PlcR at the onset of stationary
phase (12–14). The papR gene encodes a 48-amino acid
polypeptide with an N-terminal signal peptide sequence.
This signalling peptide is exported and subsequently
re-imported into the recipient cell via the oligopeptide
permease system (15). During export, PapR is cleaved to
liberate the active fragment comprising at least ﬁve
C-terminal residues. PapR speciﬁcally interacts with
PlcR inside the cell, allowing PlcR binding to its DNA
target sites (16). This triggers a positive feedback on plcR
expression and activates the expression of a regulon
comprising about 100 genes (12–14,17–19).
PlcR is composed of a N-terminal helix–turn–helix
(HTH) DNA-binding domain, and a C-terminal regula-
tory domain composed of ﬁve degenerated tetratrico-
peptide repeats (TPR) (14,20). TPRs are structurally
conserved helical domains involved in protein–protein or
protein–peptide interactions that have been identiﬁed in
a large number of proteins in prokaryotes and eukaryotes
(21). Recent crystallographic analysis shows that PapR
binds to the centre of the concave side of the TPR domain.
PapR recognition appears to trigger an allosteric mechan-
ism that rearranges the HTH domains and thus allows
DNA association (20). Structural and phylogenetic
analyses further led to the identiﬁcation of the RNPP
family (named after the key members Rap/NprR/PlcR/
PrgX) of quorum-sensing proteins. This family appears to
comprise all Gram-positive quorum-sensing systems
which bind directly to their signalling peptide in the
receiver cell.
Four groups of PlcR–PapR pairs deﬁning four distinct
pherotypes were identiﬁed: PlcRI, PlcRII, PlcRIII and
PlcRIV. These groups have been distinguished by in vivo
complementation assays focused on plcR expression in
Bacillus strain 407 and by the comparison of 29 PlcR–
PapR sequences from various isolated strains representa-
tive of the B. cereus group (16,22). Thus for a given strain,
PlcR activation depends on PapR originating from the
same strain or from a member of the same pherogroup.
Some level of speciﬁcity appeared to be determined by the
ﬁrst and the ﬁfth residue of the pentapeptide form of PapR.
The pentapeptide was identiﬁed as the minimal peptide
size required for PlcR activation. However, the length of
the physiologically relevant PapR remained elusive.
Here, we determined that the mature form of PapR
that accumulates in the medium and inside bacterial
cells corresponds to PapR C-terminal heptapeptide. We
combined structure/function analysis to determine the
molecular basis for speciﬁcity and cross-reactivity between
PlcRs and heptameric PapRs from the four pherotypes.
MATERIALS AND METHODS
Bacterial strains and growth conditions
The acrystalliferous B. thuringiensis 407 Cry
  strain (23)
was used in this study and designated as Bacillus
strain 407. The 407 (plcA0Z) containing a transcriptional
fusion between the plcA promoter and the lacZ gene, the
PapR null-mutant 407 (plcA0Z papR) and the sporulat-
ing deﬁcient 407 (spo0A) strains have been described
previously (15,16). The type strain of 7, 12 and 45
B. thuringiensis serotypes originated from the Institut
National de la Recherche Agronomique and Institut
Pasteur collection. Escherichia coli K-12 strain TG1 was
used as a host for the construction of plasmids and cloning
experiments. Plasmid DNA for the electroporation of
Bacillus was prepared from E. coli strains ET12567 or
SCS110 (Stratagene, La Jolla, CA, USA). Plasmids were
introduced by electroporation in E. coli and Bacillus
strains, as previously described (23,24).
Escherichia coli and the Bacillus were grown in Luria
Broth (LB) medium with vigorous shaking (175r.p.m.) at
378C (except for PlcR overproduction) or in a sporula-
tion-speciﬁc medium (25) for PapR puriﬁcation. The
following antibiotic concentrations were used for bacterial
selection: ampicillin 100mg/ml (for E. coli), kanamycin at
200mg/ml and erythromycin at 10mg/ml (for Bacillus).
DNA manipulations
Chromosomal DNA was extracted from Bacillus cells
using thePuregene DNA Puriﬁcation Kit (Gentra Systems,
USA). Plasmid DNA was extracted from E. coli using
QIAprep spin columns (QIAgen, France). Restriction
enzymes (New England Biolabs, USA) and T4 DNA
ligase (Invitrogen, USA) were used in accordance with
the manufacturer’s recommendations. Oligonucleotide
primers (Supplementary Table S1) were synthesized by
Proligo (Paris, France). PCRs were performed in a
thermocycler PTC-100 (MJ Research, Inc., USA).
Ampliﬁed fragments were puriﬁed using the QIAquick
PCR puriﬁcation Kit (QIAgen). Digested DNA fragments
were separated on 1% agarose gels after digestion and
extracted from gels using the QIAquick gel extraction Kit
(QIAgen).
Plasmids used for functional analysis were constructed
as follow. Wild-type or modiﬁed plcR genes with their own
promoters were ampliﬁed by PCR using chromosomal
DNA and primers described in Supplementary Table S2.
PCR fragments were digested by the appropriate enzymes
and inserted between the XbaI and HindIII or PstI sites
of pHT304 (26). The resulting plasmids and their features
are described in Supplementary Table S2. Nucleotide
sequences of cloned fragments were sequenced by Genome
Express (France).
Construction of the407 "plcR–papR recombinant strain
The thermosensitive allele exchange vector pMADplcR–
papR was constructed using the following steps. The
50 and 30 regions of the plcR–papR locus were ampliﬁed by
PCR, using primers po1/po2 and po3/orf4 (Supplemen-
tary Table S1). The 50 end was puriﬁed as a NcoI/PstI
fragment and the 30 end as an XbaI/BamHI fragment. The
kanamycin resistance gene was extracted from pDG783
(27) with PstI and XbaI. The three fragments were ligated
with NcoI- and BamHI-digested pMAD (28). Bacillus
strain 407 (plcA0Z) was electroporated with the resulting
pMADplcR–papR plasmid. The plcR–papR locus of this
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papR, as previously described (29). The resulting strain
was designated 407 (plcA0Z plcR–papR). Integration
was veriﬁed by PCR and sequencing using primers, vpo1
and vpo2 (Supplementary Table S1), complementary to
chromosomal regions ﬂanking the disrupted genes.
Functional analysis ofPapR–PlcR interactions
Bacillus strain 407 (plcA0Z plcR–papR) complemented
with plasmids containing wild-type or mutant plcR genes
with their own promoter were grown in LB medium
without antibiotics at 378C with vigorous shaking until the
onset of the stationary phase T0 (OD600 3 0.3). Each
culture was fractionated (12ml) and diﬀerent synthetic
peptides (Covalab, France) were added to a ﬁnal concen-
tration of 2mM to each fraction. These cultures were
incubated for 1h and 2ml were centrifuged (13000r.p.m.,
8min) to perform ß-galactosidase assays as previously
described (30). Each assay was repeated at least three
times.
PapRpurification
Strain 407 spo0A in sporulation-speciﬁc medium over-
expressed the PlcR regulon (31) and it minimizes
contamination by medium components; thus, we per-
formed these conditions to obtain suﬃcient quantity of
the extra-cellular form of PapR. Bacteria were grown at
378C and the supernatant was harvested at the onset of
the stationary phase (T0) by centrifugation (15min,
8000r.p.m.) and ﬁltered through 0.2mm-pore size
Nalgene ﬁlter unit. To test the presence of PapR, samples
were dried out, re-suspended in 0.2ml of LB broth and
then added to a 1ml stationary phase culture of 407
(plcA’Z ipapR) (3<OD<6). These were incubated for
2h at 378C. Then, b-galactosidase assays were performed.
Samples were puriﬁed using solid-phase extraction on a
SepPak C18 Vac 6cc cartridge (Waters, USA). The PapR
sample was eluted with 90% methanol, precipitated for 1h
on ice, centrifuged and the supernatant was dried out. The
sample, re-suspended in 100ml of 0.1% triﬂuoroacetic
acid (TFA) in water, was injected on a Superdex-peptide
HR 10/30 column (Amersham, UK) in 30% acetonitrile
(ACN), and 0.1%TFA. The activefraction wasloaded on a
mRPC column (alkyl residues C2/C18, Amersham). The
elution was performed in 20-column volume linear gradient
ranging from 25 to 35% ACN. The active samples were
loaded on a Source 5-RPC column (polystyrene/divinyl
benzene matrix, Amersham). The elution was performed in
a 10-columnvolume linear gradientrangingfrom 25to 35%
ACN. The active fractions were injected on a Satisfaction
C8+ column (C8, Cil-Cluzeau, France). The sample was
eluted in a 10-column volume linear gradient, ranging from
25 to 35% ACN. The dried PapR fraction was loaded on a
Lichrospher C18e (C18, Macherey-Nagel, Germany). The
PapR fractions were dried out and re-puriﬁed on the mRPC
column.
To extract intra-cellular PapR, wild-type 407 cells were
grown in LB till T2 (2h after the onset of the stationary
phase). Centrifuged cells were re-suspended in water and
were disrupted with glass beads as previously described (30).
Cell extract was loaded on the C18 cartridge and PapR
was eluted with 90% methanol and dried. The sample,
re-suspended in 100ml of 0.1% TFA, was puriﬁed on the
Source 5-RPC column. The active fraction was injected on
a C8+ column. The identity of the peptide was obtained
by MALDI-TOF MS (Voyager DE super STR, Applied
Biosystems, Foster City, USA) equipped with a nitrogen
laser emitting at 337nm. The peptide was re-suspended in
10ml of 10% ACN. One micro litre of peptide was mixed
on the stainless steel MALDI plate with 1ml of CHCA
(a-cyano-4-hydroxycinnamic acid, Sigma–Aldrich, Saint
Quentin Fallavier, France) at 4mg/ml in ACN/TFA
(50:50; v/v) 0.3% and dried at room temperature.
Spectra were recorded in positive reﬂector mode with
20kV as accelerating voltage, a delayed extraction time of
130ns and a 62% grid voltage and they were calibrated
using an external calibration composed of human
angiotensin II (M+H)
+=1046.5423 (Sigma, France)
and Des Arg1-bradykinin (M+H)
+=757.3997 (Sigma).
Mass spectra were analysed by Data Explorer 4.2
(Applied Biosystems, USA) with the following variables:
noise ﬁlter/smooth (noise removal of 2), 0.5% base peak
intensity, 0.5% maximum peak area and peak resolution
of 10000. Spectral proﬁles were collected in the mass
range 500–2000Da. All peptide masses were assumed
to be monoisotopic and protonated molecular ions
(M+H)
+. The vMALDI ion source—MS/MS (LTQ
Thermo Electron Corporation, San Jose, CA, USA)—was
used with an automatic Gain Control (AGC) laser
operation in order to maximize the creation of peptide
information. Peptide ions were analysed using Xcalibur
1.4 (Thermo Electron). The Data Dependant Acquisition
mode that allowed the selection of three precursor ions per
survey scan was used. Precursor mass and fragment mass
tolerance were 1.4 and 1Da, respectively.
Overproduction and purification ofPlcR
PlcR proteins were produced and puriﬁed as previously
described (16)
Anisotropy binding titration
Steady-state ﬂuorescence anisotropy binding titrations
were performed at 218C using a Beacon 2000
Fluorescence Polarization Instrument (Panvera, Corp.,
Madison, WI, USA). The concentration of the ﬂuorescein-
labelled pentapeptide LPFEF (Fl- LPFEF) was always
1.5nM and the buﬀer used was 35mM Tris–HCl, 16mM
sodium phosphate, 257mM NaCl, 0.9mM DTT and
0.05mg/ml BSA, pH 8. The concentration of the non-
labelled peptide in the competition assays was 121mM.
The anisotropy values shown correspond to the average of
ﬁve to eight measurements taken by the instrument after
equilibration. Binding data were analysed using Bioeqs
software (32). This software uses a numerical solver engine
and calculates the free energy of formation of the
complexes from the initial elements. Analysis of the
binding curves recovered in the absence of competitor
peptide was performed using a model in which a single
complex (PL
 ) was postulated. This model assumes that
each PlcR monomer (P) bound a single molecule of the
Nucleic Acids Research, 2008, Vol. 36, No. 11 3793labelled peptide (L
 ). The binding proﬁles observed in the
presence of non-labelled peptide (L) were analysed using a
model involving two complexes, PL
  and PL. The free
energy of formation, and the steady-state anisotropy
corresponding to the complex PL
  were ﬁxed to the values
recovered in the analysis of the curves obtained in the
absence of competitor. The error in the determined free
energies was estimated using rigorous conﬁdence limit
testing at the 67% conﬁdence level, in which the
uncertainties arising from parameter correlations were
taken into account.
Structural modelling
Structures were built based on the crystal structure of
PapR-bound PlcR [group I, PDB entry 2QFC, (20)] using
SWISS-MODEL. All modelled complexes were manually
adjusted and subjected to structure idealization using
REFMAC5 (33).
RESULTS
Purification of theactive form ofPapR
To determine the length of the processed active peptide,
we puriﬁed the extra- and the intra-cellular forms of PapR
from a group I strain (Bacillus strain 407). Samples were
ﬁrst fractionated by solid-phase extraction (SepPak C18
cartridge). Preliminary characterization indicated that this
peptide (thereafter called PapRI) was heat stable (908C,
20min) with a molecular mass <1000Da (it passed
through Filtron MicroSep – 1KDa ﬁlters). PapRI was
puriﬁed from the supernatant by one round of gel
ﬁltration chromatography, then by ﬁve rounds of high-
pressure chromatography, leading to a level of purity
compatible with direct mass spectrometry analysis.
At each step, only one fraction was active.
The MALDI-TOF measure of the last active chroma-
tography fraction from the supernatant led to the identi-
ﬁcation, among several mass peaks, of a (M+H)
+=
838.38Da mass peak (data not shown) corresponding to
the theoretical (M+H)
+=838.39Da mass of the hepta-
peptide PapRI (ADLPFEF). In order to disprove the
presence of other PapR forms, LC/MS-MS analyses were
performed on an active fraction. The results indicated that
the mass corresponding to the pentapeptide PapRI
( 652Da) was not recovered in this fraction. We next
characterized the 838.39Da mass using two approaches:
PSD (Post-source Decay) using MALDI-TOF (Voyager
DE STR) and the vMALDI ion source – MS/MS (Thermo
Electron Corporation). The PSD mass spectrum was
analysed using the Data Explorer software (Applied
Biosystems). Seven MS/MS masses were determined as
fragmentation masses of the sequence, ADLPFEF,
according to the theoretical fragmentation of PapRI
(Figure 1A). The data from the vMALDI-MS/MS
fragmentation were analysed using the Bioworks 3.2 soft-
ware (Thermo Electron Corporation). The xscore was
1.377 for the monocharge ion measured at (M+H)
+=
838.4Da. Seven masses for the theoretical fragmentation
of PapRI (Figure 1A) were recovered (Figure 1B), similar
to PSD mass spectrum analysis. These analyses conﬁrmed
ADLPFEF as the amino-acid sequence of PapRI.
The intra-cellular active form of the cell–cell signalling
peptide was puriﬁed after two HPLC steps and the
heptapeptide PapRI sequence was found in LC/MS-MS,
as a result of the MS/MS proﬁle obtained in PSD or
vMALDI-MS/MS. Thus, the mature and active peptide in
the extra-cellular and intra-cellular environments corre-
sponds to the last seven amino acids of PapR.
Modelling and affinity ofthe heptapeptide
Previously, we have determined the crystal structure of a
group I PlcR molecule bound to its cognate pentapeptide
LPFEF (PapR5I) (20). We used this structure to establish
a molecular model for the complex formed between PlcR
and the heptapeptide ADLPFEF (PapR7I) (Figure 2A).
In the crystal structure, the groove on PlcR that accom-
modates PapR5I continues after the N-terminal residue of
the pentapeptide. This unoccupied part of the groove is
positioned toward the C-terminal helix, and has a length
corresponding to the two additional residues of the
heptameric PapR (20). Indeed, the two additional residues
(AD) of the ADLPFEF heptapeptide (PapR7I) ﬁtted well
into the groove extension. In the resulting model, the
backbone of the N-terminal PapR7I residues, A, D and L,
is anchored to PlcR by hydrogen bonds from K204, Q241
and D244 (Figure 2B). Y207 limits the peptide-binding
groove, obstructing access for longer peptides. A salt
bridge is possible between PapR7I D and K282 from the
PlcR C-terminal helix. This model was used as a molecular
basis for our further analyses, and for modelling PlcRII,
III and IV and their cognate PapRs.
Figure 1. Theoretical fragmentation of PapRI and vMALDI-MS/MS
mass spectrum. (A) Theoretical fragmentation of the peptide
ADLPFEF (PapR7I). (B) vMALDI-MS/MS mass spectrum. Peaks in
red correspond to b ion fragmentation expected masses, and peaks
in blue to y ion fragmentation.
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peptide had a better aﬃnity to PlcR than the shorter
C-terminal PapR fragments, as it establishes more
extensive contacts with PlcR. In contrast, longer
C-terminal fragments should display a rather lower aﬃnity
due to the groove on PlcR being exactly the right size for
the heptapeptide. We determined the binding aﬃnity of
PapR-derived peptides towards PlcR using competition
experiments based on ﬂuorescence anisotropy binding
titrations. PlcR binding of the synthetic PapR5I (LPFEF)
linked to a ﬂuorescent label (ﬂuorescein) was monitored by
measuring ﬂuorescence anisotropy changes in the presence
of non-labelled peptides (Figure 3). Although ﬂuorescein
contributed to the free energy of binding, recognition
of the ﬂuorescent peptide probe was speciﬁc, as neither
direct nor competitive binding was observed using control
oligopeptides unrelated to the PapR C-terminal sequence.
Assuming a single-site interaction model, a free energy
change (iG)o f7 . 9  0.2kcal/mol corresponding to a
dissociation constant (Kd)o f1 . 3mM was measured for the
ﬂuorescent peptide. Analysis of the competition proﬁle
yielded a Kd of 41mM for the non-labelled pentapeptide
LPFEF (iG=5.9 0.2kcal/mol). The heptapeptide
(ADLPFEF) was a slightly better competitor than the 4,
5 or 9-residue PapR, displaying a Kd of 25mM (Figure 3);
this was consistent with our molecular model.
Penta- and hepta-peptides are comparable intheir
homologous activation potential
Slamti and Lereclus (2002) have shown that the PapR
minimum size able to activate PlcR was the pentapeptide.
To determine the eﬀect of the two supplementary residues
of the heptapeptide, we measured the activation level
of each cognate PlcR–PapR complex using the 5- or
the 7-amino-acid form of PapR. Plasmids containing
plcR from one of the four pherotypes (PlcRI, PlcRII,
PlcRIII or PlcRIV) (Supplementary Table S2) were intro-
duced into the Bacillus reporter strain 407 (plcA0lacZ
plcR–papR) and synthetic PapRs were added to cultures
at the onset of the stationary phase (T0). Thus, penta- or
hepta- peptides of PapRI (LPFEF, ADLPFEF), PapRII
(MPFEF, SDMPFEF), PapRIII (VPFEF, NEVPFEF)
and PapRIV (LPFEH, SDLPFEH) were added to
bacterial cultures expressing PlcRI, PlcRII, PlcRIII and
PlcRIV, respectively. The activation of the plcA promoter
was monitored using b-galactosidase assays 1h after the
peptides were added. The expression of plcA is controlled
by PlcR (14), and thus, b-galactosidase production
directly reﬂects PlcR activity in the bacterial cell. None
of the four PlcRs was active in the absence of peptides
(data not shown). Each PlcR in association with its
speciﬁc PapR (5- or 7-amino-acids long) activated the
expression the plcA0lacZ fusion (Figure 4). The results
were consistent with our in vitro binding studies showing
only a weak increase in aﬃnity for the heptapeptide—
PlcRI was similarly activated by its own speciﬁc 5- or
7-amino-acid PapRI. This was also the case for PlcRIII
and PlcRIV and their cognate PapR penta- or hepta-
peptides. However, the activity of PlcRII–PapRII was
6.5-fold greater with the heptapeptide added to the culture
than the pentapeptide (Figure 4).
Cross-talk between thefour PlcR groups
Previous studies, restricted to the speciﬁc activation of
PlcRI from Bacillus strain 407, revealed the existence
of four PlcR groups (22). To determine the relation-
ships between the four groups and the speciﬁcity of
activation for the quorum-sensing system, we measured
the activity of one PlcR from each group associated
with one of the four heptapeptides using plcA-directed
lacZ expression. This functional analysis showed
that each speciﬁc pair (PlcRI:PapRI, PlcRII:PapRII,
Figure 3. Aﬃnity of PlcR:PapR complexes. Anisotropy binding titra-
tions of the ﬂuorescein-labelled pentapeptide LPFEF (Fl- LPFEF)
with PlcR, in the absence (closed circles) and in the presence of the
competitor non-labelled peptides LPFEF (closed squares), PFEF (closed
diamonds), ADLPFEF (closed triangles), VGADLPFEF (stars) and non-
speciﬁc peptide (open squares). The concentration of Fl- LPFEF was
1.5nM and that of the competitor peptides 121mM. The Kd values shown
correspond to analysis of the competition proﬁles using the model
explained in Materials and methods section.
Figure 2. Molecular model of PapR7I bound to PlcRI. (A) Atomic
model of PlcRI:PapR7I. The structure was modelled based on PDB
entry 2QFC. The two protomers of the PlcR dimer are coloured in red
and cyan. Helices are represented by tubes, within the transparent
molecular surface. PapR7I is shown as a stick model. (B) PlcR is shown
as molecular surface and PapR7I as a stick model. Surfaces are
coloured: blue, positively charged atoms; red, negatively charged atoms;
green, hydrophobic atoms; salmon, polar oxygens; marine, polar
nitrogens; yellow, sulphur. Underlined atom labels correspond to
PlcR residues.
Nucleic Acids Research, 2008, Vol. 36, No. 11 3795PlcRIII:PapRIII and PlcRIV:PapRIV) was more active
than the heterologous pairs (Figure 5). However, speciﬁc
activities ranged from 100 Miller units (PlcRI:PapRI) to
500 Miller units (PlcRII:PapRII). PlcRI:PapRI was also
3- to 4-fold less active than the non-cognate pairs,
PlcRII:PapRI, PlcRIII:PapRI and PlcRIII:PapRII.
PlcRIII was non-speciﬁcally activated by PapRI,
PapRII, but not by PapRIV. PlcRIV was strongly and
strictly activated by its corresponding heptapeptide
(Figure 5). These results conﬁrm the existence of four
pherotypes. Furthermore, although activity of PlcRI and
PlcRIV is dependent on their cognate peptides, PlcRII and
III are less restrictive and can be activated by heterologous
PapRs.
These observations are consistent with our structural
models: PlcRI provides fewer interactions with PapR than
PlcR of other groups (Figure 6A), explaining why PlcRI
displays the lowest PapR-induced activity. In PlcRII,
K278 is well positioned to form a salt-bridge with the
heptapeptide aspartic acid (Figure 6B). The additional
binding energy may, at least in part, account for the higher
activation levels of PlcRII by PapR heptapeptides
(Figure 5). The Y275L and Y200H substitutions in
PlcRIII, combined with the PapR L3V substitution, are
predicted to pull PapR closer to the C-terminal helix
(Figure 6C). The hydrogen bond of H200 with the PapR
P4 backbone, and because H200 is smaller than Y200, will
result in the N-terminus of PapR being pulled a little
closer towards H200. Thus, PapRIII E2 appears able to
bind simultaneously to S278 and K282, and PlcRIII is
able to accommodate the slightly bulkier N-terminal
asparagine of PapRIII. PlcRIII has evolved to accom-
modate PapRIII with its bulkier N-terminal asparagine
side chain, and thus should also be able to bind the smaller
PapRI and PapRII peptides. However, the supplementary
H-bond between PlcRIII S278 and PapRIII E2 appears
inaccessible for D2 of PapRI and PapRII, explaining the
lower activation rate for these heterologous interactions.
PapRIV has the unique feature of a histidine in position 7.
On the side of PlcRIV, this is accompanied by the changes
A160S and N163S, which are positioned to form H-bonds
with the nitrogens of the H7 side chain (Figure 6D).
Together, these substitutions confer a polar, rather than a
hydrophobic interaction between PapR position 7 and the
underlying binding surface. As a result, PlcRIV will only
be activated by its corresponding peptide.
Figure 4. Comparison of the activity of the four PlcRs in association
with their cognate penta- and hepta-peptides. Synthetic penta- or
hepta- peptides of PapRI (LPFEF, ADLPFEF), PapRII (MPFEF,
SDMPFEF), PapRIII (VPFEF, NEVPFEF) and PapRIV (LPFEH,
SDLPFEH) (2mM) were added to a culture of 407 plcA0-lacZ plcR-
papR at stationary phase (OD600 3 0.3), complemented with PlcRI
(pHT304VplcRI), PlcRII (pHT304VplcRII), PlcRIII (pHT304VplcRIII)
and PlcRIV (pHT304VplcRIV), respectively. b-Galactosidase assays
were performed 1h after peptide addition. Vertical bars: SEM.
Figure 6. Model structures for the complexes formed by PlcRI–IV and
their cognate PapR heptameric peptides. Underlined atom labels
correspond to PlcR residues. (A) Molecular detail of PlcRI (ribbon
representation) in a complex with PapRI (stick model). (B) PlcRII
in a complex with PapRII. (C) PlcRIII in a complex with PapRIII.
(D) PlcRIV in a complex with PapRIV. The arrow indicates the L246
residue.
Figure 5. Cross-talk between the four PlcR groups. Synthetic hepta-
peptides PapRI (ADLPFEF), PapRII (SDMPFEF), PapRIII
(NEVPFEF) or PapRIV (SDLPFEH) (2mM) were added to a
stationary phase culture of 407 plcA0-lacZ plcR-papR (OD600
3 0.3) complemented with PlcRI, PlcRII, PlcRIII and PlcRIV,
respectively. b-Galactosidase assays were performed 1h after peptide
addition. Vertical bars: SEM.
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We next characterized the function of the interactions
between PlcR and the conserved, non-speciﬁc, PapR
hydrophobic core (FEF sequence in PapRI). Structural
analysis of the PlcR–PapR interactions showed that the
conserved PlcR K87 and K89 residues directly interact
with PapR E6 and that the aromatic PlcR Y275 residue
establishes a hydrogen bond with both PlcR K89 and
PapR E6 [Figure 2B, (20)]. Substitution of these lysines by
alanines (as a single mutation or in tandem) did not aﬀect
PlcR activity (Figure 7), suggesting that these interactions
were not important for activation. Their interactions with
PapR glutamic acids may function to selectively allow
PapR, but not other similar autoinducers, to bind PlcR.
The Y275A substitution results in a 2-fold increase of the
PlcR response (Figure 7). The Y275 side chain stabilizes
the position of the C-terminal capping helix of PlcR by
intercalating with the preceding TPR repeat. In the PlcRI–
PapRI complex, this C-terminal helix is quite mobile, as
witnessed by above average B-factors (20). Possibly, a
slight inward movement of this helix contributes to PlcR
activation. This action may be facilitated in the Y275A
mutant.
The C-terminal helix ofPlcR is required butnot
sufficient for specific PapR-mediated activation
To investigate the regions of PlcR conferring speciﬁcity
towards PapR, 29 PlcR sequences were compared (22).
This analysis revealed seven characteristic PlcRs, which
diﬀered only in their TPR domains (Figure 8).
Furthermore, only position 278 characterizes the four
speciﬁc PlcR groups: at position 278, group I PlcRs
contained an alanine, group II a lysine, group III a serine
and group IV a threonine (Figure 8). Inspection of the 3D
PlcRI model showed that A278 is located on the
C-terminal helix, oriented towards the bound PapRI
heptapeptide (Figure 2). To investigate the role of the
C-terminal helix of PlcR and speciﬁcally of its residue 278,
the following constructions have been done: (i) a PlcR
molecule was truncated at position 278, (ii) three chimeric
molecules were constructed by exchanging the C-terminal
ends starting from the position 278 of PlcRI with that
of the three other groups and (iii) PlcRI A278 was
substituted by K278 according to PlcRII sequence.
Chimeras between PlcRI and PlcRII, PlcRI and PlcRIII,
PlcRI and PlcRIV were called PlcRI’II, PlcRI’III and
PlcRI’IV, respectively. PlcRI A278K substitution was
called PlcRA278K (Supplementary Table S2). The PlcR
constructs were introduced into the plcR–papR-null
mutant 407 strain. The constructs were then functionally
analysed by testing their ability to activate a lacZ reporter
fused to the plcA promoter, in response to various PapRs.
None of the chimeras, PlcRI’II, PlcRI’III and PlcRI’IV,
was active in the absence of peptide (data not shown).
Truncated PlcR could not activate lacZ expression in
response to PapR addition (Figure 9A), suggesting that
the C-terminal helix is required for PlcR activation or
protein stability. Indeed, we cannot assure the stability of
the mutant form, or its correct folding because immuno-
detection of cytosolic PlcR (either truncated or wild type)
was unsuccessful.
The PlcRI’II chimera was similarly activated by both
PapRI and PapRII. This activation was about 2-fold
greater than that of wild-type PlcRI by PapRI, and 2-fold
less than that of PlcRII by PapRII (Figure 9B). The
PlcRI’III chimera was activated about 2-fold better by
PapRI than PlcRI. However, PlcRI’III was not activated
by PapRIII (Figure 9C). According to the structural
models (Figure 6C), the PapRIII valine is highly speciﬁc to
PlcRIII, requiring a leucine in position 275 of PlcR.
Indeed, a V3 to L3 modiﬁed PapRIII (NELPFEF) partly
restores the PlcRI’III-activating potential, but it is still
less than that observed with PapRI (ADLPFEF). The
PlcRI’IV chimera also showed an intermediate phenotype
in relation to the PapRI and PapRIV peptides
(Figure 9D). The PlcRA278K mutant was activated by
both PapRI and PapRII. This activation was similar to
PlcRI’II response (Figure 9B). Altogether, these studies
suggest a role for the C-terminal PlcR helix in modulating
PapR response. In addition, it appears that this role is in
part due to the 278 residue. All chimeric proteins were
more responsive to PapRI than wild-type PlcRI. We
investigated structural and sequence data highlighting
positions 278 and 281 to understand better why all
chimeric proteins were more responsive to PapRI than
PlcRI. In groups II, III and IV, these positions provide
side chains capable of forming ionic or polar bonds with
E2 or D2 of PapR. The increase in chimera reactivity to
PapRI can therefore be, at least partly, explained by
greater aﬃnities for PapRI. In turn, the PlcRI portion of
the chimera is less optimal for PapRII, III and IV, in
relation to their aﬃnity and thus, activation capacity is
diminished. Additionally, position 283 might also play a
role: PlcRII, III and IV, but not PlcRI have an amino acid
with a long aliphatic side chain in this location (M, M and
K, respectively, as opposed to I in PlcRI). These side
chains point towards the preceding TPR motif, as
observed as a result of the Y275A mutation, but these
Figure 7. Activation of modiﬁed PlcR proteins. Synthetic heptapeptides
of PapRI (ADLPFEF) (2mM) were added to a culture of 407 plcA0-lacZ
plcR–papR (OD600 3 0.3) at stationary phase complemented with
PlcRK87A, PlcRK89A, PlcRK87A-K89A and PlcRY275A, respectively.
The PlcR–PapR complex activity was measured by b-galactosidase assays
1h after peptide addition. Vertical bars: SEM.
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We cannot exclude that these residues contribute partly to
activation by modulating the stability and position of the
C-terminal helix.
DISCUSSION
Dissecting specificity and function in thePapR/PlcR
quorumsensing
Quorum-sensing peptides that bind to a membrane
receptor, such as the competence stimulating factor from
B. subtilis and Streptococcus species and the virulence Agr
signal in Staphylococcus, have been characterized and
puriﬁed in the culture medium (34–37). In contrast,
signalling peptides that bind directly to the eﬀector
(PlcR, Rap phosphatases) have more often been identiﬁed
on the basis of genetic studies (4,16,38). Nevertheless,
Solomon et al. (39) have identiﬁed an extra-cellular
peptide that controls, via Rap phosphatase, the
competence/sporulation pathways in B. subtilis. In this
study, we puriﬁed a processed active PapR in the culture
supernatant from a group I strain (Bacillus strain 407) and
showed that the detectable form of secreted PapR is the
heptapeptide ADLPFEF. In addition, this heptapeptide
was also found in the cytoplasm, suggesting that PapR
does not undergo further processing during or after
uptake. However, the isolation of the heptapeptide does
not preclude the presence of other minor undetectable
active forms.
The PlcR-related Rap-Phr competence and sporulation
system in B. subtilis involves the cleavage of the signalling
peptide in the extra-cellular medium by one or several
peptidases such as subtilisin, Vpr and Epr (40). The
cleavage of Phr requires an alanine residue just before
the N-terminus of the cleavable peptide bond (41). In
B. subtilis strain 168, introduction of plcR and papR genes
activate the expression of PlcR-regulated genes (12,14),
indicating that PapR processing also occurs in this
heterologous host. The heptapeptide PapR sequence is
Figure 8. Sequence alignment of seven representative PlcR sequences. Sequence alignment of seven representative PlcRs was performed with JalView,
using the Blosum62 colouring scheme. The strain names are indicated in parentheses and the roman numbers refer to the PlcR groups. Based on
3D-structure, HTH domain and TRP domains are indicated in yellow and in blue, respectively. The a-helices from the HTH domain are in green.
The ﬁrst and the last a-helices from TPR domains are in light yellow and in orange, respectively. Asterisks represent PlcR residues implicated in
PapR binding. Position 278 is coloured in red.
3798 Nucleic Acids Research, 2008, Vol. 36, No. 11also preceded by an alanine. Apart from suggesting that
PapR is 7-amino-acid-long, these results also suggest that
Phr and PapR might be processed via a similar
mechanism.
Our results conﬁrmed that the PapR pentapeptides
retained the ability to activate PlcR of all groups.
However, pentapeptides displayed a slightly lower aﬃnity
for their cognate PlcR molecule than heptapeptides.
Furthermore, pentapeptides were less group-selective.
Indeed, the PlcRII activity is lower with its cognate
pentapeptide PapRII than with the heterologous penta-
peptide PapRI (Supplementary Figure S1). We have
previously reported that the N-terminal amino acid of
the PapR pentapeptide is implicated in selection; thus, we
conclude that the three N-terminal residues of PapR direct
group speciﬁcity. Our anisotropy assays and structural
analysis support that the impact of these residues lies
mainly in modulating the aﬃnity of a given PapR towards
various PlcR groups. The K87A and K89A mutants did
not abolish PlcR activation by PapR, suggesting that
activation of PlcR by PapR is mainly triggered by the
hydrophobic interactions of PapR residues 3, 5 and 7
(L, F and F in PapRI) with helices 5 and 7 of the TPR-
containing domain of PlcR. We speculate that lysines 87
and 89 function as gatekeepers, selecting PapR from other
oligopeptides by ionic interactions with the glutamic acid
of the FEF PapR core motif. Similarly, the central proline
residue may be required for the PapR peptides to ﬁt into
the binding groove on PlcR, thus helping discriminate
against other cell–cell signalling peptides.
Our results also highlight a role for the residue 278
within the PlcR C-terminal capping helix in speciﬁc
activation. PapR may enhance the TPR modiﬁcations
necessary for activation by pulling the PlcR C-terminal
helix a little towards the centre of the molecule.
Hydrophobic interactions between PlcR Y275 and PapR
L3, and polar interactions between PlcR Y275 and PapR
E4 appear important for this eﬀect; PlcR group-speciﬁc
residues between position 278 and the C-terminus also
appear important. The enhanced activity of the PlcR
Y275A mutant indicates that a slight rearrangement of the
C-terminal helix accompanies PlcR activation. We can,
however, not exclude a role of this helix in recruiting
additional components.
Figure 9. Activation of chimeric PlcR proteins. Synthetic heptapeptides of PapRI (ADLPFEF), PapRII (SDMPFEF), PapRIII (NEVPFEF) or
PapRIV (SDLPFEH) (2mM) were added to a culture of 407 plcA0-lacZ plcR–papR (OD600 3   0.3) at stationary phase complemented with PlcRI,
PlcRI0stop (A), PlcRI0II and PlcRA278K (B), PlcRI0III (C) and PlcRI0IV (D), respectively. The PlcR–PapR complex activity was measured by
b-galactosidase assays 1h after peptide addition. Vertical bars: SEM.
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The plcR and papR genes are adjacent on the bacterial
chromosome. Structural and phylogenetic analyses (20)
and the observation that a fused PlcR–PapR protein is
able to activate the PlcR regulon (42) support that the
plcR and papR gene ancestors were initially one single
gene. Our results now infer that following their separation,
selective pressure on plcR and papR genes has led to their
co-evolution, producing distinct PlcR/PapR groups. The
mutation rate of PlcR is higher than that of other
chromosomal genes, whereas inactivation of PlcR by a
nonsense mutation in the B. anthracis strains leads to a
low mutation rate similar to other chromosomal genes
(43). The plcR sequence analysis showed that mutations
are not clustered, both at the nucleotide and amino acid
levels (43); however, the PlcR residues that interact with
the non-selective core motif of PapR are conserved, except
for the F7 to H7 mutation seen in the highly speciﬁc
PlcRIV (Figure 8). Together, these observations support
that eﬃcient bacterial survival requires PlcR to associate
with PapR, but also to allow variability and adaptability of
this interaction, achieving strain-speciﬁcity among Bacilli.
Ji et al. (44) suggested that group-speciﬁc diﬀerences in
the expression of virulence factors or other extra-cellular
factors in Staphylococcus could be related to diﬀerences in
disease patterns. However, current data in relation to
PlcR-regulated virulence do not appear to corroborate a
link between virulence characteristics and PlcR/PapR
groups: the pathogenic B. cereus strains 391–98 [respon-
sible for the death of three people (45)] and G9241
[possessing the anthrax toxin genes and a functional PlcR
regulon (10)] belonged both to PlcR group IV, whereas the
virulence of other group IV strains has not been high-
lighted (i.e. B. thuringiensis serotype 45 type strain,
B. thuringiensis Bt51 and B. weihenstephanensis KBAB4).
In contrast, several mammalian pathogen strains belong
to the PlcRIII group: B. thuringiensis 97-27 subsp.
konkukian, isolated from a necrotic human wound (46);
B. cereus E33L, isolated from a carcass swab (47); and
the major producer of commercially used biopesticides,
the B. thuringiensis strain kurstaki HD1 Dipel (48).
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